164 related articles for article (PubMed ID: 2394606)
1. Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system.
Jenkin D; Goddard K; Armstrong D; Becker L; Berry M; Chan H; Doherty M; Greenberg M; Hendrick B; Hoffman H
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):265-74. PubMed ID: 2394606
[TBL] [Abstract][Full Text] [Related]
2. Childhood medulloblastoma in Ontario, 1977-1987: population-based results.
Danjoux CE; Jenkin RD; McLaughlin J; Grimard L; Gaspar LE; Dar AR; Fisher B; Whitton AC; Kraus V; Springer CD
Med Pediatr Oncol; 1996 Jan; 26(1):1-9. PubMed ID: 7494506
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma: experience of a single institution.
Wolff JE; Huettermann U; Ritter J; Straeter R; Palm D; Ruebe C; Kraehling KH; Jürgens H
Klin Padiatr; 1998; 210(4):234-8. PubMed ID: 9743958
[TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma--prognostic factors and outcome of treatment: review of the Mayo Clinic experience.
Garton GR; Schomberg PJ; Scheithauer BW; Shaw EG; Ilstrup DM; Blackwell CR; Laws ER; Earle JD
Mayo Clin Proc; 1990 Aug; 65(8):1077-86. PubMed ID: 2117687
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma--a retrospective analysis.
Awasthy BS; Das Gupta C; Singh R; Patel AK; Julka PK
Indian J Pediatr; 1997; 64(5):693-7. PubMed ID: 10771904
[TBL] [Abstract][Full Text] [Related]
6. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system.
Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR
Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930
[TBL] [Abstract][Full Text] [Related]
7. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic outcome of medulloblastoma in 49 children.
Jaing TH; Hung IJ; Yang CP; Wang HS; Hung PC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(4):279-85. PubMed ID: 7572172
[TBL] [Abstract][Full Text] [Related]
9. Survival and prognostic factors in a series of adults with medulloblastomas.
Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of posterior fossa medulloblastoma in children: The Lyon experience.
Grassiot B; Beuriat PA; Di Rocco F; Leblond P; Faure-Conter C; Szathmari A; Mottolese C
Neurochirurgie; 2021 Feb; 67(1):52-60. PubMed ID: 33482236
[TBL] [Abstract][Full Text] [Related]
11. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors.
Kao GD; Goldwein JW; Schultz DJ; Radcliffe J; Sutton L; Lange B
Cancer; 1994 Aug; 74(3):965-71. PubMed ID: 8039126
[TBL] [Abstract][Full Text] [Related]
12. Adult medulloblastoma: an analysis of survival and prognostic factors.
Le QT; Weil MD; Wara WM; Lamborn KR; Prados MD; Edwards MS; Gutin PH
Cancer J Sci Am; 1997; 3(4):238-45. PubMed ID: 9263630
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
14. [Relapse modalities in medulloblastoma].
Di Rocco C; Iannelli A; Tancredi A; Mastrangelo R; Valente A; Riccardi R; Deb G; Donfrancesco A
Pediatr Med Chir; 1994; 16(3):241-5. PubMed ID: 7971445
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma.
Wang C; Yuan XJ; Jiang MW; Wang LF
J Neurosurg Pediatr; 2016 Jan; 17(1):49-56. PubMed ID: 26451721
[TBL] [Abstract][Full Text] [Related]
16. A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation.
Caputy AJ; McCullough DC; Manz HJ; Patterson K; Hammock MK
J Neurosurg; 1987 Jan; 66(1):80-7. PubMed ID: 3783262
[TBL] [Abstract][Full Text] [Related]
17. Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
Sawamura Y; Ikeda J; Ishii N; Kato T; Tada M; Abe H; Shirato H
Neurol Med Chir (Tokyo); 1996 Sep; 36(9):632-8. PubMed ID: 8913079
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and secondary malignancies in childhood medulloblastoma.
Stavrou T; Bromley CM; Nicholson HS; Byrne J; Packer RJ; Goldstein AM; Reaman GH
J Pediatr Hematol Oncol; 2001 Oct; 23(7):431-6. PubMed ID: 11878577
[TBL] [Abstract][Full Text] [Related]
19. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma: staging and treatment outcome.
Deutsch M
Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1103-7. PubMed ID: 3384715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
